Arvaya Healthcare Limited submitted a revised disclosure to BSE Limited regarding the outcome of its Board of Directors meeting held on November 4, 2026. The revision specifically pertains to Item A(1) under the heading "Proposed Rights Issue – Draft Letter of Offer" to accurately reflect the authorization granted to the Rights Issue Committee.
Rights Issue Authorization Details
The Board authorized the Rights Issue Committee to review, finalize, approve, and adopt the Draft Letter of Offer (DLOF) for a proposed Rights Issue of partly paid-up equity shares. The authorization is in furtherance of the approval granted by the Board at its meeting held on July 11, 2026.
Financial Details
The Rights Issue is for an amount aggregating up to ₹21,000.00 lakhs (Rupees Two Hundred Ten Crore only), assuming full subscription, allotment, and receipt of all call monies.
Legal Basis
The issuance is being made pursuant to Section 62(1)(a) of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations).
Committee Authorities
The Rights Issue Committee is authorized to submit/file the DLOF with BSE Limited (the Designated Stock Exchange) along with the application for obtaining in-principle approval. The Committee can undertake all necessary acts incidental to this process in accordance with applicable laws.
Pending Decisions
The final terms of the Rights Issue, including the issue price, rights entitlement ratio, amount payable on application and on subsequent call(s), and the record date, will be decided by the Rights Issue Committee or the Board as applicable. These details will be intimated to the Stock Exchange separately in accordance with SEBI regulations.
Status of Other Disclosures
All other disclosures contained in the earlier outcome dated November 4, 2026, including disclosures relating to the Postal Ballot, remain unchanged.